Skip to main content

and
  1. Article

    Open Access

    Individualized dynamic frailty-tailored therapy (DynaFiT) in elderly patients with newly diagnosed multiple myeloma: a prospective study

    It remains a substantial challenge to balance treatment efficacy and toxicity in geriatric patients with multiple myeloma (MM), primarily due to the dynamic nature of frailty. Here, we conducted a prospective ...

    Yingjie Zhang, **nyue Liang, Weiling Xu, **ngcheng Yi in Journal of Hematology & Oncology (2024)

  2. No Access

    Article

    Identification an innovative classification and nomogram for predicting the prognosis of thyroid carcinoma patients and providing therapeutic schedules

    Thyroid carcinoma (THCA) represents a prevalent form of cancer globally, with its incidence demonstrating an upward trend in recent years. Accumulating evidence has indicated that programmed cell death (PCD) p...

    Zhanrong Feng, Qian Zhao, Ying Ding, Yue Xu in Journal of Cancer Research and Clinical On… (2023)

  3. No Access

    Article

    More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma

    Mengru Tian, **nyue Liang, Weiling Xu, **ngcheng Yi, Tingting Yue in Annals of Hematology (2023)

  4. No Access

    Article

    Identification a unique disulfidptosis classification regarding prognosis and immune landscapes in thyroid carcinoma and providing therapeutic strategies

    Thyroid carcinoma (THCA) is a common type of cancer worldwide, and its incidence has been increasing in recent years. Disulfidptosis, a recently defined form of metabolic-related regulated cell death (RCD), ha...

    Zhanrong Feng, Qian Zhao, Ying Ding, Yue Xu in Journal of Cancer Research and Clinical On… (2023)

  5. No Access

    Article

    CRM1 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas

    Gastric cancer (GC) is a highly aggressive malignant tumor. Its high mortality rate prompts the urgent need for novel therapeutic agents. The aim of this study is to detect the expression of CRM1 in GC, which...

    Fang Zhou, Wensheng Qiu, Ruyong Yao, **yu **ang, **aoxiao Sun in Medical Oncology (2013)

  6. No Access

    Article

    BMP9 inhibits the proliferation and invasiveness of breast cancer cells MDA-MB-231

    Transforming growth factor-β (TGF-β) is known to promote tumor proliferation, migration, invasion, and metastasis. Bone morphogenetic proteins (BMPs) are members of the TGF-β superfamily. Several BMPs (BMP2 an...

    Ke Wang, Honglei Feng, Wei Ren, **aoxiao Sun in Journal of Cancer Research and Clinical On… (2011)